tPAIC Assay kit CLIA

Primary DI

06974521004493

Basic UDI-DI Code

B-06974521004493

Reference

SUPM085072

Device Types

Single use

Regulation

Eu Ivdd

Classification

Eu Ivd General

Status

On The Market

Manufacturer

Shenzhen Superbio Technology Co.,Ltd.

This kit is used for in vitro quantitative detection of Tissue plasminogen activator - plasminogen activator inhibitor -1 complex (tPAIC) in human plasma samples. Plasminogen activator inhibitor-1 (PAI-1) as the main inhibitor of tissue-type plasminogen activator (t-PA) and urokinase-type plasminogen activator (u-PA), It is closely related to arteriovenous thrombosis, bleeding and coagulation abnormalities, and cell migration, which in turn causes the occurrence and development of a series of diseases such as Cerebral ischemic stroke, coronary heart disease, venous thrombosis, tumor metastasis, bleeding, necrosis of the femoral head, and miscarriage. At the same time, the active level of plasma PAI-1 in the body is regulated by blood lipids, blood sugar, etc., further involved in the process of obesity, diabetes, hyperlipidemia and other diseases, and affects the prognosis of the above related diseases.

Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).